Global Commercial Launch Preparations Underway for First Potential Approval Towards Building Specialty Cardiovascular Franchise Company Recently Launched Unbranded Disease Awareness Campaign “HCM ...

Duke-NUS scientists and their collaborators have discovered a potential new treatment for heart failure with preserved ...

Duke-NUS scientists and their collaborators have discovered a potential new treatment for heart failure with preserved ejection fraction (HFpEF), a type of heart disease that is notoriously difficult ...

We describe the epidemiology, clinical features, treatment strategies, and in‐hospital outcomes in patients ... Smooth curves of the odds of prevalence of HFrEF and HFmrEF compared with HFpEF across ...

Jason Butler, an analyst from JMP Securities, reiterated the Buy rating on Cytokinetics (CYTK – Research Report). The associated price ...

The use of mineralocorticoid receptor antagonists (MRAs) has been well established for patients with heart failure and reduced ejection fraction (HFrEF). However, the application of MRAs in patients ...